130 related articles for article (PubMed ID: 38145716)
41. Factors Associated With COVID-19 Vaccine Receipt by Health Care Personnel at a Major Academic Hospital During the First Months of Vaccine Availability.
Green-McKenzie J; Shofer FS; Momplaisir F; Kuter BJ; Kruse G; Bialal U; Behta M; O'Donnell J; Al-Ramahi N; Kasbekar N; Sullivan P; Okala P; Brennan PJ
JAMA Netw Open; 2021 Dec; 4(12):e2136582. PubMed ID: 34851399
[TBL] [Abstract][Full Text] [Related]
42. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.
Moore S; Hill EM; Tildesley MJ; Dyson L; Keeling MJ
Lancet Infect Dis; 2021 Jun; 21(6):793-802. PubMed ID: 33743847
[TBL] [Abstract][Full Text] [Related]
43. Effects of public health measures during the SARS-CoV-2 pandemic on the winter respiratory syncytial virus epidemic: An interrupted time series analysis.
Reyes Domínguez AI; Pavlovic Nesic S; Urquía Martí L; Pérez González MDC; Reyes Suárez D; García-Muñoz Rodrigo F
Paediatr Perinat Epidemiol; 2022 May; 36(3):329-336. PubMed ID: 34981845
[TBL] [Abstract][Full Text] [Related]
44. Impact of COVID-19 on accident and emergency attendances and emergency and planned hospital admissions in Scotland: an interrupted time-series analysis.
Mulholland RH; Wood R; Stagg HR; Fischbacher C; Villacampa J; Simpson CR; Vasileiou E; McCowan C; Stock SJ; Docherty AB; Ritchie LD; Agrawal U; Robertson C; Murray JL; MacKenzie F; Sheikh A
J R Soc Med; 2020 Nov; 113(11):444-453. PubMed ID: 33012218
[TBL] [Abstract][Full Text] [Related]
45. Hospital presentations for self-poisoning during COVID-19 in Sri Lanka: an interrupted time-series analysis.
Knipe D; Silva T; Aroos A; Senarathna L; Hettiarachchi NM; Galappaththi SR; Spittal MJ; Gunnell D; Metcalfe C; Rajapakse T
Lancet Psychiatry; 2021 Oct; 8(10):892-900. PubMed ID: 34332697
[TBL] [Abstract][Full Text] [Related]
46. Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control study.
Tartof SY; Slezak JM; Puzniak L; Hong V; Frankland TB; Xie F; Ackerson BK; Valluri SR; Jodar L; McLaughlin JM
Lancet Respir Med; 2023 Feb; 11(2):176-187. PubMed ID: 36216013
[TBL] [Abstract][Full Text] [Related]
47. Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case-control study.
Tartof SY; Slezak JM; Puzniak L; Hong V; Frankland TB; Ackerson BK; Xie F; Takhar H; Ogun OA; Simmons S; Zamparo JM; Valluri SR; Jodar L; McLaughlin JM
Lancet Respir Med; 2023 Dec; 11(12):1089-1100. PubMed ID: 37898148
[TBL] [Abstract][Full Text] [Related]
48. Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis.
Smith JB; Gonzales EG; Li BH; Langer-Gould A
JAMA Netw Open; 2022 Dec; 5(12):e2248664. PubMed ID: 36576740
[TBL] [Abstract][Full Text] [Related]
49. Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.
Katikireddi SV; Cerqueira-Silva T; Vasileiou E; Robertson C; Amele S; Pan J; Taylor B; Boaventura V; Werneck GL; Flores-Ortiz R; Agrawal U; Docherty AB; McCowan C; McMenamin J; Moore E; Ritchie LD; Rudan I; Shah SA; Shi T; Simpson CR; Barreto ML; Oliveira VA; Barral-Netto M; Sheikh A
Lancet; 2022 Jan; 399(10319):25-35. PubMed ID: 34942103
[TBL] [Abstract][Full Text] [Related]
50. Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study.
Bruxvoort KJ; Sy LS; Qian L; Ackerson BK; Luo Y; Lee GS; Tian Y; Florea A; Aragones M; Tubert JE; Takhar HS; Ku JH; Paila YD; Talarico CA; Tseng HF
BMJ; 2021 Dec; 375():e068848. PubMed ID: 34911691
[TBL] [Abstract][Full Text] [Related]
51. Mortality Among US Patients Hospitalized With SARS-CoV-2 Infection in 2020.
Finelli L; Gupta V; Petigara T; Yu K; Bauer KA; Puzniak LA
JAMA Netw Open; 2021 Apr; 4(4):e216556. PubMed ID: 33830226
[TBL] [Abstract][Full Text] [Related]
52. Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes.
Lin DY; Gu Y; Xu Y; Wheeler B; Young H; Sunny SK; Moore Z; Zeng D
JAMA; 2022 Oct; 328(14):1415-1426. PubMed ID: 36155617
[TBL] [Abstract][Full Text] [Related]
53. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
54. Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.
Bennett TD; Moffitt RA; Hajagos JG; Amor B; Anand A; Bissell MM; Bradwell KR; Bremer C; Byrd JB; Denham A; DeWitt PE; Gabriel D; Garibaldi BT; Girvin AT; Guinney J; Hill EL; Hong SS; Jimenez H; Kavuluru R; Kostka K; Lehmann HP; Levitt E; Mallipattu SK; Manna A; McMurry JA; Morris M; Muschelli J; Neumann AJ; Palchuk MB; Pfaff ER; Qian Z; Qureshi N; Russell S; Spratt H; Walden A; Williams AE; Wooldridge JT; Yoo YJ; Zhang XT; Zhu RL; Austin CP; Saltz JH; Gersing KR; Haendel MA; Chute CG;
JAMA Netw Open; 2021 Jul; 4(7):e2116901. PubMed ID: 34255046
[TBL] [Abstract][Full Text] [Related]
55. Sociodemographic Disparities In Access To COVID-19 Vaccines Upon Initial Rollout In Florida.
Attonito J; Van Arsdale W; Fishman K; Darya M; Jacomino M; Luck G
Health Aff (Millwood); 2021 Dec; 40(12):1883-1891. PubMed ID: 34871075
[TBL] [Abstract][Full Text] [Related]
56. The mediating effect of health literacy on COVID-19 vaccine confidence among a diverse sample of urban adults in Boston and Chicago.
Hurstak EE; Paasche-Orlow MK; Hahn EA; Henault LE; Taddeo MA; Moreno PI; Weaver C; Marquez M; Serrano E; Thomas J; Griffith JW
Vaccine; 2023 Apr; 41(15):2562-2571. PubMed ID: 36907736
[TBL] [Abstract][Full Text] [Related]
57. Trends of follow-up clinic visits and admissions three-months before and during COVID-19 pandemic at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia: an interrupted time series analysis.
Abebe W; Worku A; Moges T; Tekle N; Amogne W; Haile T; Mekonen D; Habtamu A; Deressa W
BMC Health Serv Res; 2021 Jul; 21(1):731. PubMed ID: 34301264
[TBL] [Abstract][Full Text] [Related]
58. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
Li X; Raventós B; Roel E; Pistillo A; Martinez-Hernandez E; Delmestri A; Reyes C; Strauss V; Prieto-Alhambra D; Burn E; Duarte-Salles T
BMJ; 2022 Mar; 376():e068373. PubMed ID: 35296468
[TBL] [Abstract][Full Text] [Related]
59. Risk Factors for Not Completing a 2-Dose Primary Series of Messenger RNA COVID-19 Vaccination in a Large Health Care System in Southern California: Retrospective Cohort Study.
Xu S; Hong V; Sy LS; Bruxvoort KJ; Lewin B; Han B; Holmquist KJ; Qian L
JMIR Public Health Surveill; 2023 Oct; 9():e46318. PubMed ID: 37792452
[TBL] [Abstract][Full Text] [Related]
60. COVID-19-Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study.
Cardemil CV; Dahl R; Prill MM; Cates J; Brown S; Perea A; Marconi V; Bell L; Rodriguez-Barradas MC; Rivera-Dominguez G; Beenhouwer D; Poteshkina A; Holodniy M; Lucero-Obusan C; Balachandran N; Hall AJ; Kim L; Langley G
JMIR Public Health Surveill; 2021 Jan; 7(1):e24502. PubMed ID: 33338028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
